Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

Citation
S. Genc et al., Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production, NEUROSCI L, 298(2), 2001, pp. 139-141
Citations number
13
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
ISSN journal
03043940 → ACNP
Volume
298
Issue
2
Year of publication
2001
Pages
139 - 141
Database
ISI
SICI code
0304-3940(20010202)298:2<139:EENI1>2.0.ZU;2-Q
Abstract
Erythropoietin (EPO), produced by the kidney and fetal liver, is a cytokine -hormone that stimulates erythropoiesis under hypoxic conditions. It has be en shown that EPO is produced in the central nervous system and its recepto r is expressed on neurons. Since EPO has neuroprotective effects in vitro a nd in vivo against brain injury, we investigated the effect of EPO treatmen t on locomotor activities of animals, survival of nigral dopaminergic neuro ns and nitrate levels in substantia nigra and striatum in 1-methyl-4-phenyl -1,2,3,6-tetrahydropyridine (MPTP)-induced animal model of Parkinsonism in C57/BL mice. Our findings suggest that EPO has protective and treating effe ct in MPTP-induced neurotoxicity in this mouse model of Parkinson's Disease via increasing nitric oxide production. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.